共 50 条
- [22] BIOMARKERS FOR EARLY TREATMENT RESPONSE TO BIOLOGICS IN TREATMENT OF RHEUMATOID ARTHRITIS. [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1083 - 1083
- [23] Leflunomide termination rates in comparison with others DMARDs in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S540 - S541
- [24] Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S136 - S136
- [25] Leflunomide in treatment of rheumatoid arthritis - Reply [J]. LANCET, 2002, 359 (9312): : 1158 - 1158
- [26] Is there a place for leflunomide in the treatment of rheumatoid arthritis? [J]. LANCET, 2001, 358 (9289): : 1198 - 1200
- [27] Leflunomide for the treatment of rheumatoid arthritis and autoimmunity [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (04): : 190 - 193
- [28] Infliximab and etanercept treatment in rheumatoid arthritis. A Swedish experience. [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S227 - S227
- [29] An antidestructive effect of leflunomide in early rheumatoid arthritis [J]. TERAPEVTICHESKII ARKHIV, 2006, 78 (06): : 6 - 10
- [30] Pain experience in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S244 - S244